Video

Dr Patrick Conway: How VBID Can Benefit Medicare Advantage

Patrick Conway, MD, explains why CMS looked toward value-based insurance design for Medicare Advantage plans.

Patrick Conway, MD, says that CMS is looking towards value-based insurance design for Medicare Advantage plans.

Transcript (modified)

What is it about value-based insurance design that CMS thought would make it a good fit for a Medicare Advantage Demonstration?

So we had seen value-based insurance design in the private market, we’d seen some evidence of its potential to improve quality, to lower cost, and to increase delivery of high-value services. And we’re hearing from Medicare Advantage (MA) Plans that they wanted the ability to have value-based insurance design in the MA program.

So we put forward that model where, in the process of getting applications and selecting those applications, we think incentivizing the consumer, the beneficiary, to seek out high-value services will be beneficial to Medicare Advantage plans and to our health system.

Related Videos
Tiago Biachi, MD, PhD
Irina Dralyuk
Edgardo S. Santos, MD, FACP, FASCO
Irina Dralyuk
Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine
Robin Glasco, Spencer Stuart
Edgardo S. Santos, MD, FACP, FASCO
Tiago Biachi, MD, PhD
Don M. Benson, MD, PhD, James Cancer Hospital
Edgardo S. Santos, MD, FACP, FASCO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo